BioCentury | Mar 18, 2013
Company News

Cantab Biopharmaceuticals, PolyTherics deal

...VIII product. Cantab develops enhanced versions of marketed, off-patent biologics (see BioCentury, Feb. 1, 2010). Cantab Biopharmaceuticals Ltd....
BioCentury | Nov 12, 2012
Company News

Medical Research Council pharmaceuticals news

...delivery company Arecor Ltd. (Cambridge, U.K.); neuromodulation device company Bioinduction Ltd. (Bristol, U.K.); biosimilars company Cantab Biopharmaceuticals Ltd....
BioCentury | Mar 29, 2010
Company News

Antitope, Cantab Biopharmaceuticals deal

...a hematologic indication for Cantab. Further terms were not disclosed. Antitope Ltd. , Cambridge, U.K. Cantab Biopharmaceuticals Ltd....
BioCentury | Feb 1, 2010
Company News

Cantab Biopharmaceuticals, PolyTherics deal

...also is eligible for milestones and royalties. Cantab develops enhanced versions of marketed, off-patent biologics. Cantab Biopharmaceuticals Ltd....
BioCentury | Feb 1, 2010
Company News

Cantab Biopharmaceuticals board of directors update

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K. Business: Biosimilars Appointed: Bill Henry, partner at Celtic Pharma Holdings Advisors LLP, as non-executive director; John Mayo, partner at Celtic Pharma Holdings Advisors LLP, as non-executive director; and Stephen Parker,...
BioCentury | Feb 1, 2010
Financial News

Cantab Biopharmaceuticals completes venture financing

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K. Business: Biosimilars Date completed: 1/25/10 Type: Venture financing Raised: £5 million ($8.1 million) Investor: Celtic Pharma Holdings Advisors LLP Note: Celtic committed to provide £5 million ($8.1 million) over three...
BioCentury | Feb 1, 2010
Company News

Cantab Biopharmaceuticals management update

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K. Business: Biosimilars Hired: Jim Mills as CEO, formerly director of operations at Cambridge Biomanufacturing Ltd. WIR Staff...
BioCentury | Jan 27, 2010
Company News

PolyTherics, Cantab in hematology deal

...PolyTherics Ltd. (London, U.K.) partnered with Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) to develop an undisclosed protein therapeutic in...
BioCentury | Jan 26, 2010
Financial News

Cantab gets L5 million from Celtic Pharma

Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) received a L5 million ($8.1 million) investment from Celtic Pharma Holdings Advisors LLP. Cantab is developing enhanced versions of marketed, off-patent biologics. Cantab will initially focus on hematology candidates, which...
Items per page:
1 - 9 of 9
BioCentury | Mar 18, 2013
Company News

Cantab Biopharmaceuticals, PolyTherics deal

...VIII product. Cantab develops enhanced versions of marketed, off-patent biologics (see BioCentury, Feb. 1, 2010). Cantab Biopharmaceuticals Ltd....
BioCentury | Nov 12, 2012
Company News

Medical Research Council pharmaceuticals news

...delivery company Arecor Ltd. (Cambridge, U.K.); neuromodulation device company Bioinduction Ltd. (Bristol, U.K.); biosimilars company Cantab Biopharmaceuticals Ltd....
BioCentury | Mar 29, 2010
Company News

Antitope, Cantab Biopharmaceuticals deal

...a hematologic indication for Cantab. Further terms were not disclosed. Antitope Ltd. , Cambridge, U.K. Cantab Biopharmaceuticals Ltd....
BioCentury | Feb 1, 2010
Company News

Cantab Biopharmaceuticals, PolyTherics deal

...also is eligible for milestones and royalties. Cantab develops enhanced versions of marketed, off-patent biologics. Cantab Biopharmaceuticals Ltd....
BioCentury | Feb 1, 2010
Company News

Cantab Biopharmaceuticals board of directors update

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K. Business: Biosimilars Appointed: Bill Henry, partner at Celtic Pharma Holdings Advisors LLP, as non-executive director; John Mayo, partner at Celtic Pharma Holdings Advisors LLP, as non-executive director; and Stephen Parker,...
BioCentury | Feb 1, 2010
Financial News

Cantab Biopharmaceuticals completes venture financing

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K. Business: Biosimilars Date completed: 1/25/10 Type: Venture financing Raised: £5 million ($8.1 million) Investor: Celtic Pharma Holdings Advisors LLP Note: Celtic committed to provide £5 million ($8.1 million) over three...
BioCentury | Feb 1, 2010
Company News

Cantab Biopharmaceuticals management update

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K. Business: Biosimilars Hired: Jim Mills as CEO, formerly director of operations at Cambridge Biomanufacturing Ltd. WIR Staff...
BioCentury | Jan 27, 2010
Company News

PolyTherics, Cantab in hematology deal

...PolyTherics Ltd. (London, U.K.) partnered with Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) to develop an undisclosed protein therapeutic in...
BioCentury | Jan 26, 2010
Financial News

Cantab gets L5 million from Celtic Pharma

Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) received a L5 million ($8.1 million) investment from Celtic Pharma Holdings Advisors LLP. Cantab is developing enhanced versions of marketed, off-patent biologics. Cantab will initially focus on hematology candidates, which...
Items per page:
1 - 9 of 9